The Best Crossword Puzzle Maker Online
Powered by BrightSprout
Save Status:
or to save your progress. The page will not refresh.
Controls:
SPACEBAR SWITCHES TYPING DIRECTION
Answer Key:
Edit a Copy:
Make Your Own:
Crossword Word Search Worksheet
Rate This Puzzle:
Log in or sign up to rate this puzzle.

Drug discovery: methods and principles

Across
Gleevac Tasigna Tarveca
High throughput screening methods Screening large compound libraries from Adrich •96,384,1536 well micro plates •Robots for liquid handling •Automated data capture and an
•Virtual high throughput screening methods • screening virtual compound libraries (data files-structural information of compounds and target) • molecule docking •Automated data analysis tools •Smaller group is selected for lab investigation
•Cycle begins with identification of structure (“hit”) In a relevant biological assay • new analogues with structural modifications are prepared and screened in the biogical assay • assay results improve ,changes kept, cycle repeated • changes are detrimental ,changes are discarded, cycle repeated •Process continues until candidate compound with the desired properties is identified
… to target selection • financial profit to corporates (pharmaceutical companies) • target selection set the stage for all future programs • focus on rare diseases
•Therapeutic exploration 50–400 patients •IIA therapeutic dosage set •IIB overall efficacy
Identification of technical candidate requires consideration of a variety of properties beyond activity at the biological target of interest Drug discovery optimises compound so that it has many of the following properties as possible: •Stable •Safe •Selective •Soluble •Pharmacokinetics •Novel •Active
• Most common form of dementia • Described in 1906 • >110 years gone, still no treatment • Potential targets are: • Beta-secretase (BACE) • Gamma-secretase • Glycogen synthase kinase 3beta (GSK3beta) • Cyclin-dependent kinase-5 (CDK5)
Priorities disease CETP cholestryl ester transfer protein target was linked theoretically to lipoprotein metabolism • Torcetrapib • Dalcetrapib • Ancetrapib Out of the three drugs none was approved: • CETP was discovered to not be a viable drug target •Compounds have off target effects •Pharmokinetic issues •Torcetrapib- increase in BP and mortality therefore terminated in 2006 •Target biology needs to be thoroughly understood
• Hypertension (the silent killer): • Diuretics (Midamor (Amiloride) • Beta-blockers (Tenoretic (Atenolol)) • Angiotensin-converting enzyme (ACE) inhibitors (Capoten (Captopril) Other class: HMG-CoA reductase inhibitors STATINS by blocking cholesterol production Lipitor (Atorvastatin) Zocor (Simvastatin)
Lipinski’s… • Lipitor • Lescol • Crestor both have • para-flourbenzene ring and 1,3-diol-carboxylic acid side chains- otherwise compounds are quite different to each other •All above are HMG-CoA reductase inhibitors
Molecular weight < 500 AMU log P < five < five hydrogen bond donors < five hydrogen bond acceptors <10 rotatable bonds
Down
Human pharmacology Healthy volunteers 20–50 subject Safety margins for further progression Maximum tolerated dose MTD
•methicillin-resistant Staphlococcus aureus in 1980s and 1990s. • Methicillin (Staphcillin) introduced in 1959- to treat penicillin- resistant bacteria • 2 years later- resistant strains in European hospitals. • By 1980, it spread across the globe and costs of bacterial infection treatment in US alone were- $3-$4 billion annually.
Therapeutic confirmation Large scale multicentre <a href="tel:250–1000">250–1000</a> Efficacy in standard of care New drug may be approved by the FDA
•Decreases the number of compounds at each level (filtering process) • A series of qualification that a compound must surpass in order to advance through the process
•Compound that modifies selected target • exceptionally complex and multifaceted process • CAS(chemical abstract service database) this database can be used to select compound that is going to be used into drug discovery and development • use guidance for useful drug-like biological molecules(Lipinski rule)
To examine if hit compounds need follow-up effort or not • screening decreases number of compounds to few compounds with different structural classes • structure activity relationship studied •Synthesise analogues •Biological testing
… Drugs Natural products and their derivative: Taxol Velban Adriamycin
• Virus identified- 1983 • 1987- AZT (Retrovir, azidothymidine) approved • Mechanism- first reverse transcriptase inhibitor • Over 3 decades- other drugs developed- • Viread (Tenofovir), Viracept (Nelfinavir), Crixivan (Indinavir) (HIV Protease inhibitor) • Improved treatment with HAART (highly active antiretroviral therapy)- cocktail treatment • All-in-one Complera and Stribild Modern drug discovery changed the course of AIDS epidemic in &lt;30 years
Phase 1 Phase 2 Phase 3 Phase 4 Phase 0
•Drug… •Some parts of pre-clinical overlap into the stage Proof of concept Full development Registration/launch
Drug… •Target discovery(target selection) •Lead discovery •Lead optimisation (clinical candidate selection) Throughout drug discovery there is target progression and validation Identification of a single compound happens